Related Experiment Videos

Drug interactions and pharmacokinetic risk factors when using antidepressants in the medically ill patients

L F Gram¹, K Brøsen

¹Department of Clinical Pharmacology, Odense University, Denmark.

Clinical Neuropharmacology

|January 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Genetic Polymorphisms in Organic Cation Transporter 1 Attenuates Hepatic Metformin Exposure in Humans.

Clinical pharmacology and therapeutics·2017

Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study.

Clinical pharmacology and therapeutics·2017

Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2017

Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.

Clinical pharmacology and therapeutics·2016

Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists: a self-controlled register study.

Journal of thrombosis and haemostasis : JTH·2015

Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial of the Danish University Antidepressant Group (DUAG-7).

Pharmacopsychiatry·2015

See all related articles